Screener
HealthEquity HQY Common stock, par value (in dollars per share)
Common stock, par value (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by HealthEquity in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The source filing: HealthEquity’s 10-Q, filed May 28, 2026.
- Filed
- May 28, 2026, 4:04 PM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0001428336-26-000028
| (in thousands, except par value) | April 30, 2026 | January 31, 2026 |
|---|---|---|
| Commitments and contingencies (see Note 5) | ||
| Stockholders’ equity | ||
| Preferred stock, $0.0001 par value, 100,000 shares authorized, no shares issued and outstanding as of April 30, 2026 and January 31, 2026, respectively | — | — |
| Common stock, $0.0001 par value, 900,000 shares authorized, 83,927 and 85,007 shares issued and outstanding as of April 30, 2026 and January 31, 2026, respectively | 8 | 8 |
| Additional paid-in capital | 1,901,935 | 1,916,989 |
| Accumulated earnings | 177,204 | 195,906 |
| Accumulated other comprehensive loss | (31,752) | (5,707) |
| Total stockholders’ equity | 2,047,395 | 2,107,196 |
Item 1. Financial statements
FAQ
- What is HealthEquity's common stock, par value (in dollars per share)?
- HealthEquity (HQY) reported common stock, par value (in dollars per share) of $0 in Q1 2026.
- How has HealthEquity's common stock, par value (in dollars per share) changed year-over-year?
- HealthEquity's common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for HealthEquity's common stock, par value (in dollars per share)?
- Over 5 years (2021 to 2026), HealthEquity's common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.
Ask your AI about HealthEquity's common stock, par value (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude